The project aims to study the new ways of organizing and producing technologies that characterize the new geographies of bio-technological innovation by analyzing vaccine and other immunebased products development for the so-called ‘neglected diseases’ in the Global South. The remarkably rapid pace of Covid-19 vaccine development has called into question the thesis
that the pharmaceutical industry is facing an “innovation crisis”. The industry has demonstrated its capacity for innovative vaccines based on relevant biomedical technologies. However, the landscape of global pharmaceutical development is clearly in transformation, particularly with the emergence of Global South countries as new actors in the technological development and manufacture of health products. To grasp
how healthcare innovation is evolving, it is crucial to examine emergent forms of the knowledge production, flows of research, and developmental capital across old boundaries of north and south.